Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.

Hedin, Charlotte Rose Hawkey; Sado, Gina; Ndegwa, Nelson; Lytvyak, Ellina; Mason, Andrew; Montano-Loza, Aldo; Gerussi, Alessio; Saffioti, Francesca; Thorburn, Douglas; Nilsson, Emma; Larsson, Geir; Moum, Bjørn A; van Munster, Kim N; Ponsioen, Cyriel Y; Levy, Cynthia; Nogueira, Nicholas F; Bowlus, Christopher L; Gotlieb, Neta; Shibolet, Oren; Lynch, Kate D; Chapman, Roger W; Rupp, Christian; Vesterhus, Mette; Jørgensen, Kristin K; Rorsman, Fredrik; Schramm, Christoph; Sabino, João; Vermeire, Severine; Zago, Alessandra; Cazzagon, Nora; Marschall, Hanns-Ulrich; Ytting, Henriette; Ben Belkacem, Karima; Chazouilleres, Olivier; Almer, Sven; Bergquist, Annika.

Clin Gastroenterol Hepatol ; 18(10): 2295-2304.e2, 2020 09.

Artículo en Inglés | MEDLINE | ID: mdl-32068151

2.

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch, Kate D; Chapman, Roger W; Keshav, Satish; Montano-Loza, Aldo J; Mason, Andrew L; Kremer, Andreas E; Vetter, Marcel; de Krijger, Manon; Ponsioen, Cyriel Y; Trivedi, Palak; Hirschfield, Gideon; Schramm, Christoph; Liu, Chung Heng; Bowlus, Christopher L; Estes, Derek J; Pratt, Daniel; Hedin, Charlotte; Bergquist, Annika; de Vries, Annemarie C; van der Woude, C Janneke; Yu, Lei; Assis, David N; Boyer, James; Ytting, Henriette; Hallibasic, Emina; Trauner, Michael; Marschall, Hanns-Ulrich; Daretti, Luigi M; Marzioni, Marco; Yimam, Kidist K; Perin, Nicola; Floreani, Annarosa; Beretta-Piccoli, Benedetta Terziroli; Rogers, Jennifer K; Levy, Cynthia.

Clin Gastroenterol Hepatol ; 18(1): 179-187.e6, 2020 01.

Artículo en Inglés | MEDLINE | ID: mdl-31100458

3.

Obeticholic acid-a new therapy in PBC and NASH.

Chapman, Roger W; Lynch, Kate D.

Br Med Bull ; 133(1): 95-104, 2020 05 15.

Artículo en Inglés | MEDLINE | ID: mdl-32282030

4.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Goode, Elizabeth C; Clark, Allan B; Mells, George F; Srivastava, Brijesh; Spiess, Kelly; Gelson, William T H; Trivedi, Palak J; Lynch, Kate D; Castren, Edit; Vesterhus, Mette N; Karlsen, Tom H; Ji, Sun-Gou; Anderson, Carl A; Thorburn, Douglas; Hudson, Mark; Heneghan, Michael A; Aldersley, Mark A; Bathgate, Andrew; Sandford, Richard N; Alexander, Graeme J; Chapman, Roger W; Walmsley, Martine; Hirschfield, Gideon M; Rushbrook, Simon M.

Hepatology ; 69(5): 2120-2135, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30566748

5.

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.

Culver, Emma L; Bungay, Helen K; Betts, Margaret; Forde, Colm; Buchel, Otto; Manganis, Charis; Warren, Bryan F; Cummings, Fraser R; Keshav, Satish; Travis, Simon P L; Chapman, Roger W.

Liver Int ; 40(11): 2744-2757, 2020 11.

Artículo en Inglés | MEDLINE | ID: mdl-32841490

6.

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.

de Vries, Elisabeth M; Wang, Junfeng; Williamson, Kate D; Leeflang, Mariska M; Boonstra, Kirsten; Weersma, Rinse K; Beuers, Ulrich; Chapman, Roger W; Geskus, Ronald B; Ponsioen, Cyriel Y.

Gut ; 67(10): 1864-1869, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-28739581

7.

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.

de Vries, Elisabeth M G; de Krijger, Manon; Färkkilä, Martti; Arola, Johanna; Schirmacher, Peter; Gotthardt, Daniel; Goeppert, Benjamin; Trivedi, Palak J; Hirschfield, Gideon M; Ytting, Henriette; Vainer, Ben; Buuren, Henk R van; Biermann, Katharina; Harms, Maren H; Chazouilleres, Olivier; Wendum, Dominique; Kemgang, Astrid D; Chapman, Roger W; Wang, Lai Mun; Williamson, Kate D; Gouw, Annette S H; Paradis, Valerie; Sempoux, Christine; Beuers, Ulrich; Hübscher, Stefan G; Verheij, Joanne; Ponsioen, Cyriel Y.

Hepatology ; 65(3): 907-919, 2017 03.

Artículo en Inglés | MEDLINE | ID: mdl-27880989

8.

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.

Ponsioen, Cyriel Y; Chapman, Roger W; Chazouillères, Olivier; Hirschfield, Gideon M; Karlsen, Tom H; Lohse, Ansgar W; Pinzani, Massimo; Schrumpf, Erik; Trauner, Michael; Gores, Gregory J.

Hepatology ; 63(4): 1357-67, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-26418478

9.

Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies.

Doorenspleet, Marieke E; Hubers, Lowiek M; Culver, Emma L; Maillette de Buy Wenniger, Lucas J; Klarenbeek, Paul L; Chapman, Roger W; Baas, Frank; van de Graaf, Stan F; Verheij, Joanne; van Gulik, Thomas M; Barnes, Eleanor; Beuers, Ulrich; de Vries, Niek.

Hepatology ; 64(2): 501-7, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27015613

10.

New Therapeutic Strategies for Primary Sclerosing Cholangitis.

Williamson, Kate D; Chapman, Roger W.

Semin Liver Dis ; 36(1): 5-14, 2016 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-26870928

11.

Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.

Culver, Emma L; Sadler, Ross; Simpson, Dawn; Cargill, Tamsin; Makuch, Mateusz; Bateman, Adrian C; Ellis, Anthony J; Collier, Jane; Chapman, Roger W; Klenerman, P; Barnes, Eleanor; Ferry, Berne.

Am J Gastroenterol ; 111(5): 733-43, 2016 05.

Artículo en Inglés | MEDLINE | ID: mdl-27091321

12.

Primary sclerosing cholangitis: a clinical update.

Williamson, Kate D; Chapman, Roger W.

Br Med Bull ; 114(1): 53-64, 2015 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-25981516

13.

Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.

Boonstra, Kirsten; Culver, Emma L; de Buy Wenniger, Lucas Maillette; van Heerde, Marianne J; van Erpecum, Karel J; Poen, Alexander C; van Nieuwkerk, Karin M J; Spanier, B W Marcel; Witteman, Ben J M; Tuynman, Hans A R E; van Geloven, Nan; van Buuren, Henk; Chapman, Roger W; Barnes, Eleanor; Beuers, Ulrich; Ponsioen, Cyriel Y.

Hepatology ; 59(5): 1954-63, 2014 May.

Artículo en Inglés | MEDLINE | ID: mdl-24375491

14.

The genetics of complex cholestatic disorders.

Hirschfield, Gideon M; Chapman, Roger W; Karlsen, Tom H; Lammert, Frank; Lazaridis, Konstantinos N; Mason, Andrew L.

Gastroenterology ; 144(7): 1357-74, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-23583734

15.

Primary sclerosing cholangitis.

Williamson, Kate D; Chapman, Roger W.

Dig Dis ; 32(4): 438-45, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-24969292

16.

Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.

Al Mamari, Said; Djordjevic, Jelena; Halliday, John S; Chapman, Roger W.

J Hepatol ; 58(2): 329-34, 2013 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-23085647

17.

Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.

Braden, Barbara; Halliday, Johnny; Aryasingha, Sanjeewa; Sharifi, Yalda; Checchin, Davide; Warren, Bryan F; Kitiyakara, Taya; Travis, Simon P L; Chapman, Roger W.

Clin Gastroenterol Hepatol ; 10(3): 303-8, 2012 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-22037429

18.

Cholangiocarcinoma complicating secondary sclerosing cholangitis from cryptosporidiosis in an adult patient with CD40 ligand deficiency: case report and review of the literature.

Rahman, Monira; Chapel, Helen; Chapman, Roger W; Collier, Jane D.

Int Arch Allergy Immunol ; 159(2): 204-8, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-22678466

19.

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.

Srivastava, Brijesh; Mells, George F; Cordell, Heather J; Muriithi, Agnes; Brown, Matthew; Ellinghaus, Eva; Franke, Andre; Karlsen, Tom H; Sandford, Richard N; Alexander, Graeme J; Chapman, Roger W; Rushbrook, Simon M; Melum, Espen.

Scand J Gastroenterol ; 47(7): 820-6, 2012 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-22554193

20.

Primary sclerosing cholangitis: is any treatment worthwhile?

Barnabas, Ashley; Chapman, Roger W.

Curr Gastroenterol Rep ; 14(1): 17-24, 2012 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-22124849

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Obeticholic acid-a new therapy in PBC and NASH.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.

Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies.

New Therapeutic Strategies for Primary Sclerosing Cholangitis.

Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.

Primary sclerosing cholangitis: a clinical update.

Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.

The genetics of complex cholestatic disorders.

Primary sclerosing cholangitis.

Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.

Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.

Cholangiocarcinoma complicating secondary sclerosing cholangitis from cryptosporidiosis in an adult patient with CD40 ligand deficiency: case report and review of the literature.

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.

Primary sclerosing cholangitis: is any treatment worthwhile?